Melanoma Therapeutics market worldwide is projected to grow by US$3. 9 Billion, driven by a compounded growth of 12. 4%. Cutaneous Melanoma, one of the segments analyzed and sized in this study, displays the potential to grow at over 12.

New York, Oct. 11, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Melanoma Therapeutics Industry" - https://www.reportlinker.com/p05818007/?utm_source=GNW
2%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$3.1 Billion by the year 2025, Cutaneous Melanoma will bring in healthy gains adding significant momentum to global growth.

- Representing the developed world, the United States will maintain a 11% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$152.5 Million to the region’s size and clout in the next 5 to 6 years. Over US$127.5 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Cutaneous Melanoma will reach a market size of US$158.4 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 15.8% over the next couple of years and add approximately US$924 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include among others, Amgen, Inc.; AstraZeneca PLC; Bristol-Myers Squibb Company; Eisai Co., Ltd.; F. Hoffmann-La Roche AG; Iovance Biotherapeutics, Inc.; Merck & Co., Inc.; Novartis International AG; Pfizer, Inc.


Read the full report: https://www.reportlinker.com/p05818007/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Melanoma Therapeutics Competitor Market Share Scenario
Worldwide (in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Melanoma Therapeutics Global Market Estimates and
Forecasts in US$ Million by Region/Country: 2018-2025
Table 2: Melanoma Therapeutics Global Retrospective Market
Scenario in US$ Million by Region/Country: 2009-2017
Table 3: Melanoma Therapeutics Market Share Shift across Key
Geographies Worldwide: 2009 VS 2019 VS 2025
Table 4: Cutaneous Melanoma (Type) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 5: Cutaneous Melanoma (Type) Historic Market Analysis by
Region/Country in US$ Million: 2009 to 2017
Table 6: Cutaneous Melanoma (Type) Market Share Breakdown of
Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
Table 7: Ocular Melanoma (Type) Potential Growth Markets
Worldwide in US$ Million: 2018 to 2025
Table 8: Ocular Melanoma (Type) Historic Market Perspective by
Region/Country in US$ Million: 2009 to 2017
Table 9: Ocular Melanoma (Type) Market Sales Breakdown by
Region/Country in Percentage: 2009 VS 2019 VS 2025
Table 10: Mucosal Melanoma (Type) Geographic Market Spread
Worldwide in US$ Million: 2018 to 2025
Table 11: Mucosal Melanoma (Type) Region Wise Breakdown of
Global Historic Demand in US$ Million: 2009 to 2017
Table 12: Mucosal Melanoma (Type) Market Share Distribution in
Percentage by Region/Country: 2009 VS 2019 VS 2025
Table 13: Surgery (Therapy) World Market Estimates and
Forecasts by Region/Country in US$ Million: 2018 to 2025
Table 14: Surgery (Therapy) Market Historic Review by
Region/Country in US$ Million: 2009 to 2017
Table 15: Surgery (Therapy) Market Share Breakdown by
Region/Country: 2009 VS 2019 VS 2025
Table 16: Immunotherapy (Therapy) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 17: Immunotherapy (Therapy) Historic Market Analysis by
Region/Country in US$ Million: 2009 to 2017
Table 18: Immunotherapy (Therapy) Market Share Distribution in
Percentage by Region/Country: 2009 VS 2019 VS 2025
Table 19: Targeted Therapy (Therapy) World Market Estimates and
Forecasts in US$ Million by Region/Country: 2018 to 2025
Table 20: Targeted Therapy (Therapy) Market Worldwide Historic
Review by Region/Country in US$ Million: 2009 to 2017
Table 21: Targeted Therapy (Therapy) Market Percentage Share
Distribution by Region/Country: 2009 VS 2019 VS 2025
Table 22: Chemotherapy (Therapy) Market Opportunity Analysis
Worldwide in US$ Million by Region/Country: 2018 to 2025
Table 23: Chemotherapy (Therapy) Global Historic Demand in US$
Million by Region/Country: 2009 to 2017
Table 24: Chemotherapy (Therapy) Market Share Distribution in
Percentage by Region/Country: 2009 VS 2019 VS 2025
Table 25: Radiation Therapy (Therapy) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 26: Radiation Therapy (Therapy) Historic Market Analysis
by Region/Country in US$ Million: 2009 to 2017
Table 27: Radiation Therapy (Therapy) Market Share Breakdown of
Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Melanoma Therapeutics Market Share (in %) by Company: 2019 &
2025
Table 28: United States Melanoma Therapeutics Market Estimates
and Projections in US$ Million by Type: 2018 to 2025
Table 29: Melanoma Therapeutics Market in the United States by
Type: A Historic Review in US$ Million for 2009-2017
Table 30: United States Melanoma Therapeutics Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 31: United States Melanoma Therapeutics Market Estimates
and Projections in US$ Million by Therapy: 2018 to 2025
Table 32: Melanoma Therapeutics Market in the United States by
Therapy: A Historic Review in US$ Million for 2009-2017
Table 33: United States Melanoma Therapeutics Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
CANADA
Table 34: Canadian Melanoma Therapeutics Market Estimates and
Forecasts in US$ Million by Type: 2018 to 2025
Table 35: Canadian Melanoma Therapeutics Historic Market Review
by Type in US$ Million: 2009-2017
Table 36: Melanoma Therapeutics Market in Canada: Percentage
Share Breakdown of Sales by Type for 2009, 2019, and 2025
Table 37: Canadian Melanoma Therapeutics Market Estimates and
Forecasts in US$ Million by Therapy: 2018 to 2025
Table 38: Canadian Melanoma Therapeutics Historic Market Review
by Therapy in US$ Million: 2009-2017
Table 39: Melanoma Therapeutics Market in Canada: Percentage
Share Breakdown of Sales by Therapy for 2009, 2019, and 2025
JAPAN
Table 40: Japanese Market for Melanoma Therapeutics: Annual
Sales Estimates and Projections in US$ Million by Type for the
Period 2018-2025
Table 41: Melanoma Therapeutics Market in Japan: Historic Sales
Analysis in US$ Million by Type for the Period 2009-2017
Table 42: Japanese Melanoma Therapeutics Market Share Analysis
by Type: 2009 VS 2019 VS 2025
Table 43: Japanese Market for Melanoma Therapeutics: Annual
Sales Estimates and Projections in US$ Million by Therapy for
the Period 2018-2025
Table 44: Melanoma Therapeutics Market in Japan: Historic Sales
Analysis in US$ Million by Therapy for the Period 2009-2017
Table 45: Japanese Melanoma Therapeutics Market Share Analysis
by Therapy: 2009 VS 2019 VS 2025
CHINA
Table 46: Chinese Melanoma Therapeutics Market Growth Prospects
in US$ Million by Type for the Period 2018-2025
Table 47: Melanoma Therapeutics Historic Market Analysis in
China in US$ Million by Type: 2009-2017
Table 48: Chinese Melanoma Therapeutics Market by Type:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 49: Chinese Melanoma Therapeutics Market Growth Prospects
in US$ Million by Therapy for the Period 2018-2025
Table 50: Melanoma Therapeutics Historic Market Analysis in
China in US$ Million by Therapy: 2009-2017
Table 51: Chinese Melanoma Therapeutics Market by Therapy:
Percentage Breakdown of Sales for 2009, 2019, and 2025
EUROPE
Market Facts & Figures
European Melanoma Therapeutics Market: Competitor Market Share
Scenario (in %) for 2019 & 2025
Table 52: European Melanoma Therapeutics Market Demand Scenario
in US$ Million by Region/Country: 2018-2025
Table 53: Melanoma Therapeutics Market in Europe: A Historic
Market Perspective in US$ Million by Region/Country for the
Period 2009-2017
Table 54: European Melanoma Therapeutics Market Share Shift by
Region/Country: 2009 VS 2019 VS 2025
Table 55: European Melanoma Therapeutics Market Estimates and
Forecasts in US$ Million by Type: 2018-2025
Table 56: Melanoma Therapeutics Market in Europe in US$ Million
by Type: A Historic Review for the Period 2009-2017
Table 57: European Melanoma Therapeutics Market Share Breakdown
by Type: 2009 VS 2019 VS 2025
Table 58: European Melanoma Therapeutics Market Estimates and
Forecasts in US$ Million by Therapy: 2018-2025
Table 59: Melanoma Therapeutics Market in Europe in US$ Million
by Therapy: A Historic Review for the Period 2009-2017
Table 60: European Melanoma Therapeutics Market Share Breakdown
by Therapy: 2009 VS 2019 VS 2025
FRANCE
Table 61: Melanoma Therapeutics Market in France by Type:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 62: French Melanoma Therapeutics Historic Market Scenario
in US$ Million by Type: 2009-2017
Table 63: French Melanoma Therapeutics Market Share Analysis by
Type: 2009 VS 2019 VS 2025
Table 64: Melanoma Therapeutics Market in France by Therapy:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 65: French Melanoma Therapeutics Historic Market Scenario
in US$ Million by Therapy: 2009-2017
Table 66: French Melanoma Therapeutics Market Share Analysis by
Therapy: 2009 VS 2019 VS 2025
GERMANY
Table 67: Melanoma Therapeutics Market in Germany: Recent Past,
Current and Future Analysis in US$ Million by Type for the
Period 2018-2025
Table 68: German Melanoma Therapeutics Historic Market Analysis
in US$ Million by Type: 2009-2017
Table 69: German Melanoma Therapeutics Market Share Breakdown
by Type: 2009 VS 2019 VS 2025
Table 70: Melanoma Therapeutics Market in Germany: Recent Past,
Current and Future Analysis in US$ Million by Therapy for the
Period 2018-2025
Table 71: German Melanoma Therapeutics Historic Market Analysis
in US$ Million by Therapy: 2009-2017
Table 72: German Melanoma Therapeutics Market Share Breakdown
by Therapy: 2009 VS 2019 VS 2025
ITALY
Table 73: Italian Melanoma Therapeutics Market Growth Prospects
in US$ Million by Type for the Period 2018-2025
Table 74: Melanoma Therapeutics Historic Market Analysis in
Italy in US$ Million by Type: 2009-2017
Table 75: Italian Melanoma Therapeutics Market by Type:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 76: Italian Melanoma Therapeutics Market Growth Prospects
in US$ Million by Therapy for the Period 2018-2025
Table 77: Melanoma Therapeutics Historic Market Analysis in
Italy in US$ Million by Therapy: 2009-2017
Table 78: Italian Melanoma Therapeutics Market by Therapy:
Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED KINGDOM
Table 79: United Kingdom Market for Melanoma Therapeutics:
Annual Sales Estimates and Projections in US$ Million by Type
for the Period 2018-2025
Table 80: Melanoma Therapeutics Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Type for the Period
2009-2017
Table 81: United Kingdom Melanoma Therapeutics Market Share
Analysis by Type: 2009 VS 2019 VS 2025
Table 82: United Kingdom Market for Melanoma Therapeutics:
Annual Sales Estimates and Projections in US$ Million by
Therapy for the Period 2018-2025
Table 83: Melanoma Therapeutics Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Therapy for the
Period 2009-2017
Table 84: United Kingdom Melanoma Therapeutics Market Share
Analysis by Therapy: 2009 VS 2019 VS 2025
SPAIN
Table 85: Spanish Melanoma Therapeutics Market Estimates and
Forecasts in US$ Million by Type: 2018 to 2025
Table 86: Spanish Melanoma Therapeutics Historic Market Review
by Type in US$ Million: 2009-2017
Table 87: Melanoma Therapeutics Market in Spain: Percentage
Share Breakdown of Sales by Type for 2009, 2019, and 2025
Table 88: Spanish Melanoma Therapeutics Market Estimates and
Forecasts in US$ Million by Therapy: 2018 to 2025
Table 89: Spanish Melanoma Therapeutics Historic Market Review
by Therapy in US$ Million: 2009-2017
Table 90: Melanoma Therapeutics Market in Spain: Percentage
Share Breakdown of Sales by Therapy for 2009, 2019, and 2025
RUSSIA
Table 91: Russian Melanoma Therapeutics Market Estimates and
Projections in US$ Million by Type: 2018 to 2025
Table 92: Melanoma Therapeutics Market in Russia by Type: A
Historic Review in US$ Million for 2009-2017
Table 93: Russian Melanoma Therapeutics Market Share Breakdown
by Type: 2009 VS 2019 VS 2025
Table 94: Russian Melanoma Therapeutics Market Estimates and
Projections in US$ Million by Therapy: 2018 to 2025
Table 95: Melanoma Therapeutics Market in Russia by Therapy: A
Historic Review in US$ Million for 2009-2017
Table 96: Russian Melanoma Therapeutics Market Share Breakdown
by Therapy: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 97: Rest of Europe Melanoma Therapeutics Market Estimates
and Forecasts in US$ Million by Type: 2018-2025
Table 98: Melanoma Therapeutics Market in Rest of Europe in US$
Million by Type: A Historic Review for the Period 2009-2017
Table 99: Rest of Europe Melanoma Therapeutics Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 100: Rest of Europe Melanoma Therapeutics Market
Estimates and Forecasts in US$ Million by Therapy: 2018-2025
Table 101: Melanoma Therapeutics Market in Rest of Europe in
US$ Million by Therapy: A Historic Review for the Period
2009-2017
Table 102: Rest of Europe Melanoma Therapeutics Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 103: Asia-Pacific Melanoma Therapeutics Market Estimates
and Forecasts in US$ Million by Region/Country: 2018-2025
Table 104: Melanoma Therapeutics Market in Asia-Pacific:
Historic Market Analysis in US$ Million by Region/Country for
the Period 2009-2017
Table 105: Asia-Pacific Melanoma Therapeutics Market Share
Analysis by Region/Country: 2009 VS 2019 VS 2025
Table 106: Melanoma Therapeutics Market in Asia-Pacific by
Type: Estimates and Projections in US$ Million for the Period
2018-2025
Table 107: Asia-Pacific Melanoma Therapeutics Historic Market
Scenario in US$ Million by Type: 2009-2017
Table 108: Asia-Pacific Melanoma Therapeutics Market Share
Analysis by Type: 2009 VS 2019 VS 2025
Table 109: Melanoma Therapeutics Market in Asia-Pacific by
Therapy: Estimates and Projections in US$ Million for the
Period 2018-2025
Table 110: Asia-Pacific Melanoma Therapeutics Historic Market
Scenario in US$ Million by Therapy: 2009-2017
Table 111: Asia-Pacific Melanoma Therapeutics Market Share
Analysis by Therapy: 2009 VS 2019 VS 2025
AUSTRALIA
Table 112: Melanoma Therapeutics Market in Australia: Recent
Past, Current and Future Analysis in US$ Million by Type for
the Period 2018-2025
Table 113: Australian Melanoma Therapeutics Historic Market
Analysis in US$ Million by Type: 2009-2017
Table 114: Australian Melanoma Therapeutics Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 115: Melanoma Therapeutics Market in Australia: Recent
Past, Current and Future Analysis in US$ Million by Therapy for
the Period 2018-2025
Table 116: Australian Melanoma Therapeutics Historic Market
Analysis in US$ Million by Therapy: 2009-2017
Table 117: Australian Melanoma Therapeutics Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
INDIA
Table 118: Indian Melanoma Therapeutics Market Estimates and
Forecasts in US$ Million by Type: 2018 to 2025
Table 119: Indian Melanoma Therapeutics Historic Market Review
by Type in US$ Million: 2009-2017
Table 120: Melanoma Therapeutics Market in India: Percentage
Share Breakdown of Sales by Type for 2009, 2019, and 2025
Table 121: Indian Melanoma Therapeutics Market Estimates and
Forecasts in US$ Million by Therapy: 2018 to 2025
Table 122: Indian Melanoma Therapeutics Historic Market Review
by Therapy in US$ Million: 2009-2017
Table 123: Melanoma Therapeutics Market in India: Percentage
Share Breakdown of Sales by Therapy for 2009, 2019, and 2025
SOUTH KOREA
Table 124: Melanoma Therapeutics Market in South Korea: Recent
Past, Current and Future Analysis in US$ Million by Type for
the Period 2018-2025
Table 125: South Korean Melanoma Therapeutics Historic Market
Analysis in US$ Million by Type: 2009-2017
Table 126: Melanoma Therapeutics Market Share Distribution in
South Korea by Type: 2009 VS 2019 VS 2025
Table 127: Melanoma Therapeutics Market in South Korea: Recent
Past, Current and Future Analysis in US$ Million by Therapy for
the Period 2018-2025
Table 128: South Korean Melanoma Therapeutics Historic Market
Analysis in US$ Million by Therapy: 2009-2017
Table 129: Melanoma Therapeutics Market Share Distribution in
South Korea by Therapy: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
Table 130: Rest of Asia-Pacific Market for Melanoma
Therapeutics: Annual Sales Estimates and Projections in US$
Million by Type for the Period 2018-2025
Table 131: Melanoma Therapeutics Market in Rest of
Asia-Pacific: Historic Sales Analysis in US$ Million by Type
for the Period 2009-2017
Table 132: Rest of Asia-Pacific Melanoma Therapeutics Market
Share Analysis by Type: 2009 VS 2019 VS 2025
Table 133: Rest of Asia-Pacific Market for Melanoma
Therapeutics: Annual Sales Estimates and Projections in US$
Million by Therapy for the Period 2018-2025
Table 134: Melanoma Therapeutics Market in Rest of
Asia-Pacific: Historic Sales Analysis in US$ Million by Therapy
for the Period 2009-2017
Table 135: Rest of Asia-Pacific Melanoma Therapeutics Market
Share Analysis by Therapy: 2009 VS 2019 VS 2025
LATIN AMERICA
Table 136: Latin American Melanoma Therapeutics Market Trends
by Region/Country in US$ Million: 2018-2025
Table 137: Melanoma Therapeutics Market in Latin America in US$
Million by Region/Country: A Historic Perspective for the
Period 2009-2017
Table 138: Latin American Melanoma Therapeutics Market
Percentage Breakdown of Sales by Region/Country: 2009, 2019,
and 2025
Table 139: Latin American Melanoma Therapeutics Market Growth
Prospects in US$ Million by Type for the Period 2018-2025
Table 140: Melanoma Therapeutics Historic Market Analysis in
Latin America in US$ Million by Type: 2009-2017
Table 141: Latin American Melanoma Therapeutics Market by
Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 142: Latin American Melanoma Therapeutics Market Growth
Prospects in US$ Million by Therapy for the Period 2018-2025
Table 143: Melanoma Therapeutics Historic Market Analysis in
Latin America in US$ Million by Therapy: 2009-2017
Table 144: Latin American Melanoma Therapeutics Market by
Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025
ARGENTINA
Table 145: Argentinean Melanoma Therapeutics Market Estimates
and Forecasts in US$ Million by Type: 2018-2025
Table 146: Melanoma Therapeutics Market in Argentina in US$
Million by Type: A Historic Review for the Period 2009-2017
Table 147: Argentinean Melanoma Therapeutics Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 148: Argentinean Melanoma Therapeutics Market Estimates
and Forecasts in US$ Million by Therapy: 2018-2025
Table 149: Melanoma Therapeutics Market in Argentina in US$
Million by Therapy: A Historic Review for the Period 2009-2017
Table 150: Argentinean Melanoma Therapeutics Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
BRAZIL
Table 151: Melanoma Therapeutics Market in Brazil by Type:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 152: Brazilian Melanoma Therapeutics Historic Market
Scenario in US$ Million by Type: 2009-2017
Table 153: Brazilian Melanoma Therapeutics Market Share
Analysis by Type: 2009 VS 2019 VS 2025
Table 154: Melanoma Therapeutics Market in Brazil by Therapy:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 155: Brazilian Melanoma Therapeutics Historic Market
Scenario in US$ Million by Therapy: 2009-2017
Table 156: Brazilian Melanoma Therapeutics Market Share
Analysis by Therapy: 2009 VS 2019 VS 2025
MEXICO
Table 157: Melanoma Therapeutics Market in Mexico: Recent Past,
Current and Future Analysis in US$ Million by Type for the
Period 2018-2025
Table 158: Mexican Melanoma Therapeutics Historic Market
Analysis in US$ Million by Type: 2009-2017
Table 159: Mexican Melanoma Therapeutics Market Share Breakdown
by Type: 2009 VS 2019 VS 2025
Table 160: Melanoma Therapeutics Market in Mexico: Recent Past,
Current and Future Analysis in US$ Million by Therapy for the
Period 2018-2025
Table 161: Mexican Melanoma Therapeutics Historic Market
Analysis in US$ Million by Therapy: 2009-2017
Table 162: Mexican Melanoma Therapeutics Market Share Breakdown
by Therapy: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
Table 163: Rest of Latin America Melanoma Therapeutics Market
Estimates and Projections in US$ Million by Type: 2018 to 2025
Table 164: Melanoma Therapeutics Market in Rest of Latin
America by Type: A Historic Review in US$ Million for 2009-2017
Table 165: Rest of Latin America Melanoma Therapeutics Market
Share Breakdown by Type: 2009 VS 2019 VS 2025
Table 166: Rest of Latin America Melanoma Therapeutics Market
Estimates and Projections in US$ Million by Therapy: 2018 to
2025
Table 167: Melanoma Therapeutics Market in Rest of Latin
America by Therapy: A Historic Review in US$ Million for
2009-2017
Table 168: Rest of Latin America Melanoma Therapeutics Market
Share Breakdown by Therapy: 2009 VS 2019 VS 2025
MIDDLE EAST
Table 169: The Middle East Melanoma Therapeutics Market
Estimates and Forecasts in US$ Million by Region/Country:
2018-2025
Table 170: Melanoma Therapeutics Market in the Middle East by
Region/Country in US$ Million: 2009-2017
Table 171: The Middle East Melanoma Therapeutics Market Share
Breakdown by Region/Country: 2009, 2019, and 2025
Table 172: The Middle East Melanoma Therapeutics Market
Estimates and Forecasts in US$ Million by Type: 2018 to 2025
Table 173: The Middle East Melanoma Therapeutics Historic
Market by Type in US$ Million: 2009-2017
Table 174: Melanoma Therapeutics Market in the Middle East:
Percentage Share Breakdown of Sales by Type for 2009, 2019,
and 2025
Table 175: The Middle East Melanoma Therapeutics Market
Estimates and Forecasts in US$ Million by Therapy: 2018 to 2025
Table 176: The Middle East Melanoma Therapeutics Historic
Market by Therapy in US$ Million: 2009-2017
Table 177: Melanoma Therapeutics Market in the Middle East:
Percentage Share Breakdown of Sales by Therapy for 2009, 2019,
and 2025
IRAN
Table 178: Iranian Market for Melanoma Therapeutics: Annual
Sales Estimates and Projections in US$ Million by Type for the
Period 2018-2025
Table 179: Melanoma Therapeutics Market in Iran: Historic Sales
Analysis in US$ Million by Type for the Period 2009-2017
Table 180: Iranian Melanoma Therapeutics Market Share Analysis
by Type: 2009 VS 2019 VS 2025
Table 181: Iranian Market for Melanoma Therapeutics: Annual
Sales Estimates and Projections in US$ Million by Therapy for
the Period 2018-2025
Table 182: Melanoma Therapeutics Market in Iran: Historic Sales
Analysis in US$ Million by Therapy for the Period 2009-2017
Table 183: Iranian Melanoma Therapeutics Market Share Analysis
by Therapy: 2009 VS 2019 VS 2025
ISRAEL
Table 184: Israeli Melanoma Therapeutics Market Estimates and
Forecasts in US$ Million by Type: 2018-2025
Table 185: Melanoma Therapeutics Market in Israel in US$
Million by Type: A Historic Review for the Period 2009-2017
Table 186: Israeli Melanoma Therapeutics Market Share Breakdown
by Type: 2009 VS 2019 VS 2025
Table 187: Israeli Melanoma Therapeutics Market Estimates and
Forecasts in US$ Million by Therapy: 2018-2025
Table 188: Melanoma Therapeutics Market in Israel in US$
Million by Therapy: A Historic Review for the Period 2009-2017
Table 189: Israeli Melanoma Therapeutics Market Share Breakdown
by Therapy: 2009 VS 2019 VS 2025
SAUDI ARABIA
Table 190: Saudi Arabian Melanoma Therapeutics Market Growth
Prospects in US$ Million by Type for the Period 2018-2025
Table 191: Melanoma Therapeutics Historic Market Analysis in
Saudi Arabia in US$ Million by Type: 2009-2017
Table 192: Saudi Arabian Melanoma Therapeutics Market by Type:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 193: Saudi Arabian Melanoma Therapeutics Market Growth
Prospects in US$ Million by Therapy for the Period 2018-2025
Table 194: Melanoma Therapeutics Historic Market Analysis in
Saudi Arabia in US$ Million by Therapy: 2009-2017
Table 195: Saudi Arabian Melanoma Therapeutics Market by
Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED ARAB EMIRATES
Table 196: Melanoma Therapeutics Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Million by Type for the Period 2018-2025
Table 197: United Arab Emirates Melanoma Therapeutics Historic
Market Analysis in US$ Million by Type: 2009-2017
Table 198: Melanoma Therapeutics Market Share Distribution in
United Arab Emirates by Type: 2009 VS 2019 VS 2025
Table 199: Melanoma Therapeutics Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Million by Therapy for the Period 2018-2025
Table 200: United Arab Emirates Melanoma Therapeutics Historic
Market Analysis in US$ Million by Therapy: 2009-2017
Table 201: Melanoma Therapeutics Market Share Distribution in
United Arab Emirates by Therapy: 2009 VS 2019 VS 2025
REST OF MIDDLE EAST
Table 202: Melanoma Therapeutics Market in Rest of Middle East:
Recent Past, Current and Future Analysis in US$ Million by Type
for the Period 2018-2025
Table 203: Rest of Middle East Melanoma Therapeutics Historic
Market Analysis in US$ Million by Type: 2009-2017
Table 204: Rest of Middle East Melanoma Therapeutics Market
Share Breakdown by Type: 2009 VS 2019 VS 2025
Table 205: Melanoma Therapeutics Market in Rest of Middle East:
Recent Past, Current and Future Analysis in US$ Million by
Therapy for the Period 2018-2025
Table 206: Rest of Middle East Melanoma Therapeutics Historic
Market Analysis in US$ Million by Therapy: 2009-2017
Table 207: Rest of Middle East Melanoma Therapeutics Market
Share Breakdown by Therapy: 2009 VS 2019 VS 2025
AFRICA
Table 208: African Melanoma Therapeutics Market Estimates and
Projections in US$ Million by Type: 2018 to 2025
Table 209: Melanoma Therapeutics Market in Africa by Type: A
Historic Review in US$ Million for 2009-2017
Table 210: African Melanoma Therapeutics Market Share Breakdown
by Type: 2009 VS 2019 VS 2025
Table 211: African Melanoma Therapeutics Market Estimates and
Projections in US$ Million by Therapy: 2018 to 2025
Table 212: Melanoma Therapeutics Market in Africa by Therapy: A
Historic Review in US$ Million for 2009-2017
Table 213: African Melanoma Therapeutics Market Share Breakdown
by Therapy: 2009 VS 2019 VS 2025

IV. COMPETITION

AMGEN
ASTRAZENECA PLC
BRISTOL-MYERS SQUIBB COMPANY
EISAI CO.
F. HOFFMANN-LA ROCHE AG
IOVANCE BIOTHERAPEUTICS, INC.
MERCK & CO., INC.
NOVARTIS INTERNATIONAL AG
PFIZER

V. CURATED RESEARCH
Read the full report: https://www.reportlinker.com/p05818007/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001